# The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis

> **NCT01015456** · PHASE3 · TERMINATED · sponsor: **Chulalongkorn University** · enrollment: 59 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** mycophenolate sodium
- **DRUG:** cyclophosphamide

## Key facts

- **NCT ID:** NCT01015456
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 59 (ACTUAL)
- **Why stopped:** Data Safety Monitoring Board concerning of the participants' safety
- **Last updated:** 2014-10-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01015456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01015456, "The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01015456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*